Blanche & Irwin Lerner
Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues
Today is your last chance to make an impact during Rutgers University's Giving Days. Support Rutgers Business School! Give to the Dean's Excellence Fund!
Irwin Lerner (BS'51, MBA'58), the former chair, president, and CEO of Hoffmann-La Roche, is a highly regarded industry pioneer. He led industry reforms that streamlined Federal Drug Administration (FDA) drug approvals; oversaw passage of the Prescription Drug User Fee legislation, which expedited the approval process by increasing resources available to the FDA; and is credited with originating the concept of copromotion, whereby two companies join forces to market a drug. Mr. Lerner attributes much of his success to the support of his wife, Blanche, for whom the center is also named.